Latest news about the Spanish National Cancer Research Centre -

H12O-CNIO Lung Cancer Clinical Research Unit

Translational
03.12.2018 The New England Journal of Medicine (NEJM). An international clinical trial extends the effectiveness of immunotherapy to more lung cancer patients The strategy for triggering the patient’s own immune system to attack cancer, immunotherapy, is...

WISE
23.11.2018 The CNIO joins the Stem Talent Girl Madrid project On Saturday 24th November at 12 Noon, the Auditorium of the Spanish National Cancer Research Centre...

H12O-CNIO Haematological Malignancies Clinical Research Unit

Translational
21.11.2018 Haematologica. A new methodology predicts the risk of relapse in patients with acute myeloid leukemia The acute myeloid leukemia (AML) is the most common haematological cancer in adults. With a 5-year...

21.11.2018 CNIO researchers participate in the 13th Congress of the Spanish Group of Cancer Patients True to its commitment to raise awareness about cancer research, Spanish National Cancer Research...

20.11.2018 Manuel Valiente, selected to become an EMBO Young Investigator The European Molecular Biology Organisation (EMBO) has chosen Manuel Valiente, Head of the Brain...

Events
16.11.2018 Politicians undertake the implementation of urgent measures to protect and promote science in Spain Representatives from member institutions of the Severo Ochoa and María de Maeztu alliance (SOMMa),...

Translational
13.11.2018 European Urology. First blood-based biomarker in response to the treatment of the most aggressive prostate cancer In collaboration with British and Italian researchers

07.11.2018 Scott Lowe, from the Memorial Sloan Kettering, chooses the CNIO for a sabbatical stay in Spain At the 10th edition of the Visiting Researchers Programme run by the Jesús Serra Foundation (from...

Outreach to Society
05.11.2018 CNIO & The City: The history of cancer [Subtitles available in English] Cancer is a disease that has always been present, affecting all...

News